Skip to Main Content

468

Views

0

CrossRef citations to date

0

Altmetric

Bio-inspired and biomedical materials

A high-throughput lysosome trafficking assay guides ligand selection and elucidates differences in CD22-targeted nanodelivery

Hannah J. Vaughana Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USACorrespondence[email protected]
View further author information

,

Savannah Est-Wittea Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

,

Lance T. Dockerya Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

,

Morgan A. Urelloa Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

,

Jonathan Boydb Discovery Sciences, BioPharma R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

,

Brittany D. Keysera Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

,

Li Zhuanga Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

,

Marcello Marellia Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USAView further author information

&

R. James Christiea Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USAView further author information